Home/Filings/4/0001437749-16-039384
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001437749-16-039384

$NBYCIK 0001389545operating

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:24 PM ET

Size

4.3 KB

Accession

0001437749-16-039384

Insider Transaction Report

Form 4
Period: 2016-09-30
WU MIJIA
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2016-09-30$3.15/sh+15,873$50,00047,619 total
Footnotes (1)
  • [F1]Shares acquired through the exercise of warrants issued in the May 2015 private placement with China Kington Asset Management

Documents

1 file

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:24 PM ET
Size
4.3 KB